Metaraminol Wockhardt Uk

Metaraminol, the active ingredient in Metaraminol Wockhardt Uk, is an alpha‑adrenergic agonist presented as an injectable solution for intravenous use. It is employed to treat acute hypotension, including hypotension that occurs during anesthesia and in septic shock, by rapidly increasing vascular tone and blood pressure.

GNH USA supplies Metaraminol Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metaraminol is a vasopressor used in the management of low‑blood‑pressure states.

- Acute hypotension: restores systemic blood pressure in patients with sudden drops in arterial pressure. - Hypotension during anesthesia: maintains hemodynamic stability throughout surgical procedures. - Septic shock: supports circulatory pressure when vasodilatory shock is present. - Post‑operative hypotension: helps stabilize patients experiencing blood‑pressure fall after surgery.

Metaraminol may produce a range of adverse reactions, from mild to severe.

Common Side Effects: - Tachycardia: rapid heart rate due to reflex sympathetic activation. - Headache: pressure changes in cerebral vessels. - Nausea: gastrointestinal upset. - Sweating: increased sympathetic output. - Anxiety: heightened central nervous system stimulation. - Palpitations: awareness of irregular heartbeats.

Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure that can endanger organs. - Cardiac arrhythmias: abnormal heart rhythms including ventricular tachycardia. - Myocardial ischemia: reduced heart‑muscle blood flow leading to chest pain. - Tissue necrosis at injection site: local vascular injury from extravasation. - Reflex bradycardia: paradoxical slowing of heart rate. - Pulmonary edema: fluid accumulation in lungs due to abrupt pressure changes.

Metaraminol requires careful monitoring and specific safety measures.

- Blood pressure monitoring: continuously observe arterial pressure to avoid overshoot. - Coronary artery disease: use cautiously in patients with known heart‑vascular disease. - Bolus administration: avoid rapid large boluses; administer slowly to reduce cardiovascular stress. - Renal impairment: adjust dosing and monitor renal function as drug clearance may be affected. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metaraminol can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effects. - Other potent sympathomimetics (e.g., epinephrine): may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt reflex tachycardia. - Calcium channel blockers: can enhance hypotensive effects. - General anesthetics: may potentiate cardiovascular depression. - Diuretics: may exacerbate volume depletion and hypotension.